MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,262,390 | -37.3% | 1,426,239 | -22.1% | 0.00% | -50.0% |
| Q2 2023 | $22,755,775 | -35.9% | 1,830,714 | -27.7% | 0.00% | -50.0% |
| Q1 2023 | $35,486,386 | +35.8% | 2,532,932 | +38.7% | 0.00% | +33.3% |
| Q4 2022 | $26,131,750 | -21.5% | 1,826,118 | +40.1% | 0.00% | -40.0% |
| Q3 2022 | $33,279,000 | -58.7% | 1,303,506 | -54.0% | 0.01% | -50.0% |
| Q2 2022 | $80,545,000 | -19.7% | 2,835,117 | -0.3% | 0.01% | -28.6% |
| Q1 2022 | $100,273,000 | -5.1% | 2,843,021 | +12.8% | 0.01% | +7.7% |
| Q4 2021 | $105,607,000 | -15.6% | 2,520,453 | -1.1% | 0.01% | -23.5% |
| Q3 2021 | $125,058,000 | +56.7% | 2,548,051 | +33.3% | 0.02% | +54.5% |
| Q2 2021 | $79,783,000 | +59.0% | 1,911,878 | +35.8% | 0.01% | +57.1% |
| Q1 2021 | $50,173,000 | +6643.7% | 1,407,795 | +5207.2% | 0.01% | – |
| Q4 2020 | $744,000 | – | 26,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |